JDM Financial Group’s TriSalus Life Sciences TLSI Stock Holding History

JDM Financial Group’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.41K	Hold	530	–	–	﹤0.01%	300
2026 Q1	$2.12K	Hold	530	–	–	﹤0.01%	297
2025 Q4	$3.7K	Hold	530	–	–	﹤0.01%	226
2025 Q3	$2.46K	Hold	530	–	–	﹤0.01%	262
2025 Q2	$2.89K	Hold	530	–	–	﹤0.01%	241
2025 Q1	$2.93K	Hold	530	–	–	﹤0.01%	234
2024 Q4	$2.65K	Hold	530	–	–	﹤0.01%	248
2024 Q3	$2.44K	Hold	530	–	–	﹤0.01%	240
2024 Q2	$2.93K	Hold	530	–	–	﹤0.01%	211
2024 Q1	$5.17K	Buy	+530	New	+$4.89K	﹤0.01%	182

Other funds holding TLSI

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

JDM Financial Group's TLSI Position: Q2 2026 in Review

JDM Financial Group held its TriSalus Life Sciences (TLSI) position steady in Q2 2026 at 530 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #300.

JDM Financial Group first reported a position in TLSI in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.17K in Q1 2024. 79 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

JDM Financial Group held 530 shares of TriSalus Life Sciences worth $2.41K as of Q2 2026.
JDM Financial Group left its TriSalus Life Sciences share count unchanged in Q2 2026.
TriSalus Life Sciences made up ﹤0.01% of JDM Financial Group's portfolio in Q2 2026, its #300 holding.
JDM Financial Group first reported a position in TriSalus Life Sciences in Q1 2024 and has held it in 10 quarters since.
JDM Financial Group's TriSalus Life Sciences position peaked at $5.17K in Q1 2024.
79 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on JDM Financial Group's 13F filing for Q2 2026, filed 18 Aug 2026.